opencancer.ai

Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Applies drugs to a patient's fresh tumor tissue to show which options the cancer is likely to respond to before treatment begins.

Vetted listing
Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why Nagourney exists

Nagourney Cancer Institute provides CLIA-certified functional testing (EVA/PCD) for solid and hematologic tumors. Drugs and combinations are applied to the patient's fresh tumor tissue and the response is observed directly, with turnaround ranging from two days to six weeks. For a patient choosing between treatments, results can add confidence that a drug will work. Obtaining fresh tumor tissue can be a limitation.

Results in approximately 7 daysCLIA license · CLIA ID 05D0871981California state license · CDPH State ID CLF-00010526Research base · More than 10,000 patient studies and over 100 peer-reviewed manuscripts and abstractsOperator · Rational Therapeutics, LLC, directed by Dr. Robert Nagourney
  1. 1

    Send a tumor sample

    Samples are sent for analysis from across the USA and internationally.

  2. 2

    Functional profiling in the lab

    The lab measures how the patient's living cancer cells respond to drugs and drug combinations.

  3. 3

    Results in about 7 days

    A report is returned in approximately 7 days.

  4. 4

    Guide treatment with the findings

    Patients and their oncologists use the results to help select treatment.

Prefer the source? Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)'s own site has more.

Get started with Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors) handles billing.

We don't have confirmed insurance details for Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors) yet. Start a coverage check with your plan, or contact the provider directly.

Common questions about Nagourney

How does Nagourney work?

1. Send a tumor sample — Samples are sent for analysis from across the USA and internationally. 2. Functional profiling in the lab — The lab measures how the patient's living cancer cells respond to drugs and drug combinations. 3. Results in about 7 days — A report is returned in approximately 7 days. 4. Guide treatment with the findings — Patients and their oncologists use the results to help select treatment.

How long does Nagourney take?

Results in approximately 7 days

How do I connect with Nagourney?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Understand this before you decide

The testing process

Guide from Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Patient stories

Guide from Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Ask about this service

Answers grounded in Nagourney's details here. Educational only; your oncologist directs treatment.

Ask OpenCancer · answers grounded in this storefront

Who this is for

Cancer types served

bladderbloodbrainbreastcolorectalgastroesophagealgynecologichead & neckkidneyliverlungmelanomaovarianpancreaticprostatesarcoma

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.

Tempus

6 offerings

Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.

Protean Biodiagnostics

3 offerings

Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.

Get personalized guidance for your case

This page is general information. Upload your records for analysis specific to YOUR diagnosis.

Upload Records →Ask a Question →
Back to all services